Page 129 - 南京医科大学自然版
P. 129
第45卷第3期 李 奇，秦亚娟，唐立钧. 帕金森病标志物α⁃突触核蛋白聚集抑制剂的研究进展［J］.
2025年3月 南京医科大学学报（自然科学版），2025，45（3）：404-417 ·417 ·
［64］PERNI M，GALVAGNION C，MALTSEV A，et al. A natu⁃ et al. 5⁃Nitro⁃1，2⁃benzothiazol⁃3⁃amine and N⁃ethyl⁃1⁃
ral product inhibits the initiation of α⁃synuclein aggrega⁃ ［（ethylcarbamoyl）（5⁃nitro⁃1，2⁃benzothiazol⁃3⁃yl）amino］
tion and suppresses its toxicity［J］. Proc Natl Acad Sci U formamide modulate α⁃synuclein and Tau aggregation［J］.
S A，2017，114（6）：E1009-E1017 ACS Omega，2023，8（22）：20102-20115
［65］ ZHANG R Y，SUN F L，ZHANG L，et al. Tetrahydroxys⁃ ［71］ZHAO Y D，ZHANG W，XING L Z，et al. In vitro inhibi⁃
tilbene glucoside inhibits α ⁃ synuclein aggregation and tion of α⁃synuclein aggregation and disaggregation of pre⁃
apoptosis in A53T α⁃synuclein⁃transfected cells exposed formed fibers by polyphenol hybrids with 2 ⁃ conjugated
to MPP［J］. Can J Physiol Pharmacol，2017，95（6）：750- benzothiazole［J］. Bioorg Med Chem Lett，2024，105：
758 129752
［66］FENG S L，GUI J J，QIN B Q，et al. Resveratrol inhibits ［72］ ZHANG W，LIU W，ZHAO Y D，et al. The potential of
VDAC1 ⁃ mediated mitochondrial dysfunction to mitigate Rhein’s aromatic amines for Parkinson’s disease preven⁃
pathological progression in Parkinson’s disease model［J/ tion and treatment：α ⁃ synuclein aggregation inhibition
OL］. Mol Neurobiol，2024，DOI：10.1007/s12035 ⁃ 024 ⁃ and disaggregation of preformed fibers［J］. Bioorg Med
04234⁃0 Chem Lett，2024，97：129564
［67］ALBANI D，POLITO L，BATELLI S，et al. The SIRT1 ac⁃ ［73］SINGH P，AKHTAR A，ADMANE N，et al. The antiviral
tivator resveratrol protects SK⁃N⁃BE cells from oxidative drug ribavirin effectively modulates the amyloid transfor⁃
stress and against toxicity caused by alpha⁃synuclein or mation of α ⁃ synuclein protein［J］. Comput Biol Chem，
amyloid⁃beta（1⁃42）peptide［J］. J Neurochem，2009，110 2024，112：108155
（5）：1445-1456 ［74］CUI Z，GUO F Y，LI L，et al. Brazilin⁃7⁃acetate，a novel
［68］SASHIDHARA K V，MODUKURI R K，JADIYA P，et al. potential drug of Parkinson’s disease，hinders the forma⁃
Discovery of 3⁃arylcoumarin⁃tetracyclic tacrine hybrids as tion of α ⁃ synuclein fibril，mitigates cytotoxicity，and
multifunctional agents against Parkinson’s disease［J］. decreases oxidative stress［J］. Eur J Med Chem，2024，
ACS Med Chem Lett，2014，5（10）：1099-1103 264：115965
［69］ WANG Z P，ZHANG W，XING L Z，et al. Therapeutic ［75］ XING L Z，ZHANG W，ZHAO Y D，et al. Pyrazolamide
potential of coumarin⁃polyphenolic acid hybrids in PD： derivatives inhibit α⁃synuclein aggregation，disaggregate
inhibition of α ⁃ syn aggregation and disaggregation of preformed fibers，and reduce inclusion formation in
preformed fibrils，leading to reduced neuronal inclusion neuron cells［J］. Eur J Med Chem，2024，268：116198
formation［J］. Bioorg Med Chem Lett，2024，99：129618 ［收稿日期］ 2024-11-18
［70］RAMIREZ E，GANEGAMAGE S K，ELBATRAWY A A， （本文编辑：蒋 莉）
